English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1826]
News [2766]
Articles [207]
Editorials [1]
Conferences [136]
elearning [13]
Study identifies characteristics that may increase a breast cancer survivor's risk of developing leukaemia following treatment
Study identifies characteristics that may increase a breast cancer survivor's risk of developing leukaemia...
SABCS 2015: T-DM1 improved overall survival for heavily pretreated patients with HERr2-positive breast cancer
SABCS 2015: T-DM1 improved overall survival for heavily pretreated patients with HERr2-positive breast cancer
SABCS 2015: Eribulin mode of action and potential combos ID'd
SABCS 2015: Eribulin mode of action and potential combos ID'd
NICE give go ahead for olaparib and enzalutamide, but not abiraterone
NICE give go ahead for olaparib and enzalutamide, but not abiraterone
Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple-negative breast cancer
Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple...
SABCS 2015: Adding carboplatin to presurgery chemo improved disease-free survival for patients with TNBC
SABCS 2015: Adding carboplatin to presurgery chemo improved disease-free survival for patients with TNBC
Nanotech drug delivery shows promise for improved melanoma treatment
Nanotech drug delivery shows promise for improved melanoma treatment
Drugs prevent heart damage during breast cancer treatment, study shows
Drugs prevent heart damage during breast cancer treatment, study shows
SABCS 2015: Capecitabine improved outcomes for breast cancer patients with residual disease after presurgery chemotherapy
SABCS 2015: Capecitabine improved outcomes for breast cancer patients with residual disease after presurgery...
SABCS 2015: Women with luminal a subtype of breast cancer did not benefit from adjuvant chemotherapy
SABCS 2015: Women with luminal a subtype of breast cancer did not benefit from adjuvant chemotherapy
<1...219220221222223...277>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top